The King of Rock 'n' Roll's death at 43 in 1977 has remained shrouded in mystery, but medical experts who reviewed the sealed ...

Scientists claim to have found a way to restore vision in people with a common developmental eye disorder by “rebooting” the retina to its early state, enabling it to grow and cure itself.Researchers ...

Strategy Inc. (NASDAQ:MSTR) is one of the best cryptocurrency stocks to buy for the long term. On November 11, TD Cowen ...

A small but growing body of research and clinical trials suggest that injecting polynucleotides can rejuvenate skin, not only ...

Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

EyePoint Pharmaceuticals' DURAVYU trials for wet AMD receive positive DSMC review, highlighting safety and potential for ...

A popular emergency room doctor has issued a stark warning to the millions of people who fall asleep curled up on their side ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

The approvals come as a pleasant surprise for Regeneron, analysts say, helping bolster the overall product profile of high-dose Eylea despite outstanding manufacturing concerns.